Universe Pharmaceuticals INC Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Sep2019 Sep2020 Sep2021 Sep2022 Sep2023 Sep2024
Operating Activities
Net Income 0.01B0.01B0.01B-0.01B-0.01B-0.01B
Depreciation and Depletion 0.00B0.00B0.00B0.00B0.00B0.00B
Deferred Taxes -0.00B-0.00B-0.00B-0.00B0.00B
Gains from Investment Securities -0.00B-0.00B0.00B0.00B0.00B0.00B
Asset Writedowns and Impairment 0.00B0.00B-0.00B0.00B-0.00B0.00B
Cash from Operations 0.01B0.01B-0.00B-0.00B0.00B-0.01B
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) 0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables -0.00B0.00B0.00B0.00B-0.00B0.00B
Change in Inventory -0.01B-0.00B0.00B-0.00B0.00B-0.00B
Change in Account Payables -0.00B0.00B0.00B-0.00B0.00B0.00B
Change in Accured Expenses 0.00B-0.00B0.00B0.00B0.00B-0.00B
Change in Taxes -0.00B0.00B-0.00B-0.00B0.00B0.00B
Other Working Capital Changes 0.00B-0.00B0.00B0.00B-0.00B0.00B
Investing Activities
Capital Expenditures 0.00B0.00B0.00B0.00B0.00B0.00B
Sales of Property, Plant and Equipment 291.00523.000.00B
Change in Intangibles 0.00B
Acquisitions 0.00B0.00B
Change in Acquisitions & Divestments 0.02B0.01B0.01B
Cash from Investing Activities -0.00B-0.00B-0.03B-0.00B-0.00B-0.00B
Financing Activities
Other financing activities 0.00B0.00B0.00B
Cash from Financing Activities -0.02B0.00B0.03B0.00B-0.00B0.03B
Debt Issuance and Repayment
Non-Current Debt 166,666.67B
Net Debt Issuances and Repayments 166,666.67B
Dividend Payments
Dividends Paid - Common 0.02B
Additional items
Exchange Rate Effect -0.00B0.00B0.00B-0.00B-0.00B0.00B
Change in Cash -0.00B0.01B-0.00B-0.00B-0.00B0.02B
Beginning Cash Balance 0.01B0.00B0.01B0.01B0.01B0.01B
Free Cash Flow 0.01B0.01B-0.00B-0.00B0.00B-0.01B
Net Cash Flow -0.00B0.01B-0.00B-0.00B-0.00B0.02B